Protocolized Treatment Is Associated With Decreased Organ Dysfunction in Pediatric Severe Sepsis*

Pediatric Critical Care Medicine - United States
doi 10.1097/pcc.0000000000000858
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Treatment of Severe Sepsis With Artemether-Lumefantrine Is Associated With Decreased Mortality in Ugandan Patients Without Malaria

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2009English

Sepsis Bundle Adherence Is Associated With Improved Survival in Severe Sepsis or Septic Shock

Western Journal of Emergency Medicine
MedicineEmergency Medicine
1996English

Cardiovascular Insufficiency, Abdominal Sepsis, and Patients’ Age Are Associated With Decreased Paraoxonase-1 (PON1) Activity in Critically Ill Patients With Multiple Organ Dysfunction Syndrome (MODS)

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Pediatric Multiple Organ Dysfunction Syndrome

Pediatric Critical Care Medicine
Child HealthCritical CarePediatricsPerinatologyIntensive Care Medicine
2017English

Severe and Persistent Thyroid Dysfunction Associated With Tetracycline-Antibiotic Treatment in Youth

Journal of Pediatrics
Child HealthPediatricsPerinatology
2016English

Drotrecogin Alfa Activated as a Treatment for Severe Sepsis in Pediatric Cancer

Bone Marrow Transplantation
TransplantationHematology
2006English

Splenic Volume in Severe Sepsis Is Associated With Disease Severity and Pneumococcal Infection

Acute Medicine & Surgery
2016English

Is Early Ventricular Dysfunction or Dilatation Associated With Lower Mortality Rate in Adult Severe Sepsis and Septic Shock? A Meta-Analysis

Critical Care
Critical CareIntensive Care Medicine
2013English

Polymicrobial Sepsis Is Associated With Decreased Hepatic Oxidative Phosphorylation and an Altered Metabolic Profile

Journal of Surgical Research
Surgery
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy